Comment on

• Risk factors for candidemia in critically ill infants: a matched case-control study.

  Feja KN, Wu F, Roberts K, Loughrey M, Nesin M, Larson E, Della-Latta P, Haas J, Cimiotti J, Saiman L. Feja KN, et al. J Pediatr. 2005 Aug;147(2):156-61. doi: 10.1016/j.jpeds.2005.02.021. J Pediatr. 2005. PMID: 16126040 Free PMC article.
• Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.

  Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Bertini G, et al. J Pediatr. 2005 Aug;147(2):162-5. doi: 10.1016/j.jpeds.2005.02.020. J Pediatr. 2005. PMID: 16126042
• Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.

  Healy CM, Baker CJ, Zaccaria E, Campbell JR. Healy CM, et al. J Pediatr. 2005 Aug;147(2):166-71. doi: 10.1016/j.jpeds.2005.04.016. J Pediatr. 2005. PMID: 16126043
• Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.

  Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Kaufman D, et al. J Pediatr. 2005 Aug;147(2):172-9. doi: 10.1016/j.jpeds.2005.03.036. J Pediatr. 2005. PMID: 16126045 Clinical Trial.